Key Takeaways
- NuScale Power (SMR) climbed 14.7% during regular trading to approximately $11.76, followed by a 5% after-hours advance.
- A UK government initiative to fund small modular reactor (SMR) development sparked the sector-wide rally.
- RBC’s Chris Dendrinos maintains a Sector Perform rating with a $14 target, cautioning investors about chasing momentum.
- Ongoing class-action lawsuits related to ENTRA1 disclosure claims pose continued legal risk, with April 20 marking the lead-plaintiff filing deadline.
- Company insiders dumped more than 14 million shares totaling approximately $171M over the past three months, including 13.5 million shares sold by a single director.
Shares of NuScale Power experienced a sharp 14.7% rally on Wednesday, reaching an intraday peak of $12.02 before closing near $11.76. The upward momentum extended into extended trading, where the stock tacked on an additional 5%. Trading volume surged to approximately 57.5 million shares, representing a 119% increase over typical daily activity.
NuScale Power Corporation, SMR
The primary driver behind the surge was a funding initiative announced by the United Kingdom government aimed at accelerating the deployment of small modular reactors. While NuScale isn’t a direct recipient of these funds, the announcement elevated optimism throughout the nuclear energy sector. Market participants interpreted the move as evidence that government authorities are becoming increasingly committed to supporting advanced nuclear technologies.
Broader market dynamics also played a supportive role. With risk sentiment improving in recent sessions, longer-duration growth narratives such as NuScale have attracted renewed investor interest. The company operates at the intersection of energy independence, carbon reduction initiatives, and escalating power requirements for AI data centers — themes that have been resonating strongly with market participants.
A separate announcement regarding a Rolls-Royce SMR contract provided additional momentum, pushing US-traded SMR stocks higher across the board. NuScale captured gains from both the positive sentiment shift and probable short-position unwinding.
Analyst Maintains Conservative Stance
Chris Dendrinos from RBC Capital Markets remains measured in his assessment. While he recognizes that NuScale is “headed in the right direction with incremental progress,” he emphasizes that the path toward a Final Investment Decision (FID) remains “lengthy.” His Sector Perform rating stands unchanged, and he has adjusted his price target downward while increasing discount rate assumptions to account for heightened execution uncertainty.
Dendrinos highlights that NuScale’s success hinges significantly on external variables — particularly regulatory approvals and securing third-party capital. Prolonged development timelines increase the probability of shareholder dilution and complicate valuation modeling. While his $14 price objective suggests roughly 20% appreciation potential from current trading levels, he advises against aggressively pursuing the stock at these prices.
Wall Street sentiment overall remains divided. Current analyst ratings break down to 5 Buys, 6 Holds, and 1 Sell — translating to a Moderate Buy consensus — with a mean price target of $17.39, suggesting approximately 48.5% upside if the company can deliver on its operational roadmap.
Among the more optimistic voices, Bank of America lifted its rating to Neutral in January with a $28 price objective. Texas Capital issued a Strong Buy recommendation in late January. However, UBS reduced its target to $13, Canaccord dramatically cut its outlook from $60 to $25, and Citigroup holds a Sell rating with an $11.50 target. The consensus average lands at $20.96.
Significant Challenges Persist
Underlying financial performance remains concerning. NuScale reported earnings per share of -$0.80 in its most recent quarter, substantially missing the -$0.10 analyst consensus. Revenue totaled just $1.81 million versus expectations of $8.76 million. The company’s net margin stands at a troubling -1,130%.
Insider disposition activity has been substantial. The chief executive sold 82,667 shares in early March. A board member liquidated 13.5 million shares valued at approximately $163 million in April. Combined insider sales over the trailing 90-day period reached 14.1 million shares worth $171 million. Current insider ownership has declined to merely 1.2% of outstanding stock.
Legal exposure continues through active class-action litigation. Multiple law firms are advancing claims connected to alleged ENTRA1 disclosure violations, with April 20 established as the deadline for lead-plaintiff motions. The lawsuits contend that material misrepresentations contributed to an earlier stock decline of approximately 12%.
Technical indicators show the 50-day moving average positioned at $12.41, while the 200-day moving average rests at $21.21.
